platforms

Executive Overview For decades, the traditional drug research and development (R&D) pipeline has been characterized by staggering costs, astronomical attrition rates, and glacial timelines. Bringing a single new therapeutic to market typically consumes upwards of a decade and billions of dollars, with the vast majority of promising candidates failing long before they ever reach clinical…